Postdoctoral researcher at @BOOMchemistry @EdinburghUni | 👨🏻‍🔬💊 Chemistry, Drug Discovery, Kinases, Bodyboarding, Hot Peppers |

Edinburgh, Scotland
Joined September 2016
If you are interested in drug discovery and want to know more about all the approved small molecule kinase inhibitors, their medical indication, pharmacology and original synthesis, check out our last perspective! @ACSBioMed @EdinUni_IGC @BOOMchemistry pubs.acs.org/doi/10.1021/acs…
7
12
Álvaro Lorente Macías retweeted
🌞Delighted to see our work with @VSmerBarreto @jucaacoco @BOOMchemistry and the Carragher lab on featured in the press today! thetimes.co.uk/article/ai-fi… news.sky.com/story/ai-helps-…
8
14
910
Álvaro Lorente Macías retweeted
💊📢 New paper on #AI for #drugdiscovery in @NatureComms We discovered three senolytics - compounds that kill 'zombie cells' in therapies vs cancer and others #aging doi.org/10.1038/s41467-023-3… The most fun collab led by @VSmerBarreto with @jucaacoco lab #compchem #synbio
1
17
2
43
10,571
Álvaro Lorente Macías retweeted
Interested to learn more on how molecular organisation, handedness and configuration can aid in synthetic biomaterial design? Check out our recent review here ➡️ pubs.rsc.org/en/content/arti… @ChemSocRev @rcontmont, Amanda Ellis, @PalliThordarson and @jonathan_steed
1
7
3
18
Álvaro Lorente Macías retweeted
For those interested in #bioorthogonal catalysis, check out this new application just published in @angew_chem in collaboration with @BeckerLabCRTD onlinelibrary.wiley.com/doi/…
4
10
Interested in the chemistry behind approved kinase inhibitors? Check out the comprehensive perspective in Journal of Medicinal Chemistry by @BOOMchemistry here: fal.cn/3iYbC
10
13
Álvaro Lorente Macías retweeted
Nuvectis Pharma has licensed rights to develop and commercialize a novel, SRC/YES1 inhibitor discovered at the CRUK Edinburgh Centre @EdinCRC of the University of Edinburgh’s Institute of Genetics and Cancer @EdinUni_IGC. Read more on Yahoo! Finance 👇: finance.yahoo.com/news/nuvec…
2
7
2
15
Álvaro Lorente Macías retweeted
10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @EdinCRC, @MRC_CRH and @CIB_CSIC!! cancerres.aacrjournals.org/c…
2
14
1
21
Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi mdpi.com/1173114 @MDPIOpenAccess @ISGLOBALorg @ffarmaciaUGR @genyo_pts @jjdmochon @BOOMchemistry
5
8
Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells dlvr.it/S1r9XG
Check out our synthetic strategy to diversify purine libraries for drug discovery. Online on @ChemRxiv doi.org/10.26434/chemrxiv.13… @BOOMchemistry @jjdmochon
Álvaro Lorente Macías retweeted
New video: Simulating an epidemic. What happens when people avoid each other for the most part but still go to a common central location like a store? What if you can track and isolate cases, but 20% slip through the cracks? 50%? And much more. youtu.be/gxAaO2rsdIs
106
2,070
474
5,056
Álvaro Lorente Macías retweeted
Calling all medicinal chemists! We released ~60 structures of fragments bound to the Mpro #SARS_COV_2. diamond.ac.uk/covid-19/for-s… We are crowdsourcing ideas for what to synthesise and test next covid.postera.ai/covid you design it and we'll test the best designs. please RT!
22
434
39
430
Álvaro Lorente Macías retweeted
Why outbreaks like coronavirus spread exponentially, and how to “flatten the curve” wapo.st/39MCAqB
465
3,449
906
6,625
Álvaro Lorente Macías retweeted
Small Molecules of the Month, Feb. 2020 - drug-hunter.com/2020/03/01/s… Highlights from SMDD campaigns published online Jan-Feb. Grab a coffee and use this post as a starting point in getting caught up on the literature this year! PDF and links to articles in the post #chemtwitter
2
46
5
132